Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Pandemics and Biosecurity
9JUN

Salmonella cluster crosses ten EU borders

2 min read
09:58UTC

ECDC is tracking 83 Salmonella Stanley ST2045 cases across 10 EU countries since December, with children over-represented and chicken-based products the suspected vehicle.

ScienceDeveloping
Key takeaway

A shared ingredient in convenience food spread one Salmonella strain across ten EU countries at once.

ECDC is tracking a cluster of Salmonella Stanley ST2045 (a specific genetic sequence type of the bacterium) covering 83 cases in 10 EU countries since late December 2025, with children and young adults over-represented 1. Salmonella is a common cause of food poisoning; what makes this cluster notable is its spread across borders rather than its severity. The suspected vehicle is chicken-flavoured instant noodles or processed chicken sharing a common ingredient, and the cluster remains active.

The over-representation of children among the 83 cases is the detail worth holding. A shared ingredient routed through a popular convenience food reaches young consumers efficiently, which is how a low-profile Salmonella strain has turned up in ten member states at once rather than in one. The geographic spread points to a single supply chain, not ten separate kitchens.

A joint ECDC and European Food Safety Authority (EFSA) Rapid Outbreak Assessment is due 1 July; EFSA is the EU body that co-publishes these assessments on foodborne clusters. Until it identifies the shared ingredient and its distributor, the cluster stays open, and the practical relevance for readers is the recall path once the source product is named. The WHO drug-resistance action plan adopted in late May set the backdrop: the food chain carries both resistant bacteria and ordinary pathogens, and this chicken-linked cluster is the second kind reaching ten countries at once.

Deep Analysis

In plain English

Salmonella is a common cause of food poisoning, typically from undercooked chicken, eggs, or contaminated produce. Symptoms include diarrhoea, stomach cramps, and fever lasting a few days; infants and people with weakened immune systems face the most serious risk. ECDC has found 83 people across 10 European countries infected with the same specific genetic strain, called Salmonella Stanley ST2045, since late December 2025. Children and young adults appear more often than average in these cases. Investigators suspect chicken-flavoured instant noodles or a shared processed-chicken ingredient as the source. An official assessment is due 1 July.

Deep Analysis
Root Causes

Multi-country Salmonella clusters linked to processed chicken products follow a structural supply chain logic: a shared ingredient , suspected here to be a flavouring or protein isolate in chicken-flavoured instant noodles , is produced at a single manufacturing point and distributed to multiple national markets.

The ECDC's identification of Denmark as the source country for the cluster strain, with isolates matching across Austria, Czechia, Estonia, France, Germany, Lithuania, the Netherlands, and the UK, is consistent with a centralised EU food ingredient distribution hub.

The over-representation of children and young adults in the case profile is consistent with the suspected vehicle: instant noodles are consumed disproportionately by younger demographics and are often prepared without the full cooking temperatures that would destroy Salmonella in a contaminated ingredient.

The ST2045 sequence type is novel enough to produce a clear genomic signal across national reporting systems , without whole-genome sequencing, this cluster would likely have appeared as routine background Salmonella noise in each country separately.

What could happen next?
  • Risk

    The cluster is still active as of ECDC Week 23, with no product recall announced. Until the 1 July EFSA-ECDC Rapid Outbreak Assessment identifies and removes the contaminated source ingredient, new cases will continue to accumulate in all 10 affected countries.

First Reported In

Update #6 · Ebola outbreak gets an R0, and a fork

ECDC· 9 Jun 2026
Read original
Different Perspectives
World Health Organization
World Health Organization
WHO's DON606 recalibration to confirmed-only reporting gives the clean baseline the CDC model rests on, but the apparent fall from 1,040 to 534 carries misinterpretation risk WHO communications have not pre-empted. The PABS deadlock ahead of IGWG7 and continuing MBP134/remdesivir assessment without authorisation make WHO the body most able to accelerate the two decisions that could change the outbreak's trajectory.
European Union (ECDC)
European Union (ECDC)
ECDC's Week 23 CDTR tracked four simultaneous non-Ebola signals: the Dermatophilus congolensis novel-transmission cluster across France, Germany and Spain; a 4.2-fold malaria surge in Mayotte; the Salmonella ST2045 multi-country cluster; and two new Saudi MERS cases. The continental early-warning layer is carrying a full multi-pathogen picture while Bundibugyo dominates headlines.
Uganda
Uganda
Uganda's 19 confirmed cases are concentrated in Kampala and Wakiso, an urban cluster that applied the 2022 Sudan-ebolavirus playbook; the Bwera border laboratory shortens cross-border confirmation to same-day. Uganda's regulatory authority must co-sign before MBP134 or remdesivir can dose any patient.
Democratic Republic of the Congo
Democratic Republic of the Congo
Kinshasa shares Bundibugyo sequence data in real time with no treaty-guaranteed access to the vaccines that data informs, and its health minister called the US entry ban discriminatory while negotiating an early lift. DRC accounts for 515 of 534 confirmed cases and faces IS-controlled access blockades in Mambasa that health authorities cannot resolve.
United States (HHS/CDC)
United States (HHS/CDC)
HHS expanded the Ebola entry ban to green-card holders on 5 June, widening a restriction expiring around 17 June against WHO advice. The CDC simultaneously published the R0=2.51 modelling, the sharpest analytical contribution to the response, from a federal bench that holds the NIH and acting CDC director roles in one person.
Imperial College London / Cori and Ferguson
Imperial College London / Cori and Ferguson
Anne Cori and Neil Ferguson place the case-fatality ratio at 30 to 40 per cent and read the 6.8-to-1 suspected-to-confirmed ratio as evidence that the laboratory figure understates true lethality. Many people die before a swab reaches them.